13F COMBINATION REPORT
DC Funds, LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001398344-25-015410
Total Value
$2.2M
Positions
3
Other Managers
0
Confidential Omitted
No
Holdings (3)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TSCAN THERAPEUTICS INC | TCRX | 630,000 | $913,500 | 42.43% |
| 2 | WEREWOLF THERAPEUTICS INC | HOWL | 589,102 | $642,121 | 29.83% |
| 3 | BARINTHUS BIOTHERAPEUTICS PL | BRNS | 642,204 | $597,314 | 27.74% |